| Peroxisome proliferator activated receptor alpha | Successful target | Peroxisome proliferater-activated receptor alpha;PPARalpha;PPAR-alpha | Hyperinsulinemia;Obesity;Insulin resistance;Lipid metabolic disorders;Hyperglycemia | AVE0897;AVE0897;Indeglitazar;MK-767 (KRP-297);GSK-677954;AR-H049020;ZYH-1;AVE-0847;ONO-5129;LG-101280;SAR351034;Sodelglitazar;Aleglitazar;DRF 10945;LY-518674;KRP-101;GFT-505;Bezafibrate;Oxeglitazar;ZYH-7;Lobeglitazone;GFT14;Netoglitazone;Ciprofibrate;Ciprofibrate;GW-501516;Naveglitazar;Reglixane;E-3030;MURAGLITAZAR;Ragaglitazar;Fenofibrate;BM-17.0744;FARGLITAZAR;NS-220;AVE-8134;Imiglitazar;LY-929;CS-038;TESAGLITAZAR;GW-409544;K-877;CDT-fenofibrate;AD-4833;MP-136 | L-796449;Deoxy-Bigchap;GW-501516;L-165461;(E)-12-Nitrooctadec-12-enoic Acid;(E)-13-Nitrooctadec-12-enoic Acid;BMS-687453;MURAGLITAZAR;(9Z,12E)-12-nitrooctadeca-9,12-dienoic acid;Ragaglitazar;FARGLITAZAR;KRP-297;PIRINIXIC ACID;TESAGLITAZAR;GSK-9578 | |